ID   TRXR1_RAT               Reviewed;         499 AA.
AC   O89049; Q5U344; Q9JKZ3; Q9JKZ4; Q9R1I3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 5.
DT   02-OCT-2024, entry version 181.
DE   RecName: Full=Thioredoxin reductase 1, cytoplasmic {ECO:0000305};
DE            Short=TR;
DE            EC=1.8.1.9 {ECO:0000269|PubMed:10849437};
DE   AltName: Full=NADPH-dependent thioredoxin reductase;
DE   AltName: Full=Peroxidase TXNRD1 {ECO:0000305|PubMed:10849437};
DE            EC=1.11.1.2 {ECO:0000269|PubMed:10849437};
DE   AltName: Full=Thioredoxin reductase TR1;
GN   Name=Txnrd1 {ECO:0000312|RGD:61959}; Synonyms=Trxr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Neuroblastoma;
RX   PubMed=9535831; DOI=10.1074/jbc.273.15.8581;
RA   Zhong L., Arner E.S.J., Ljung J., Aaslund F., Holmgren A.;
RT   "Rat and calf thioredoxin reductase are homologous to glutathione reductase
RT   with a carboxyl-terminal elongation containing a conserved catalytically
RT   active penultimate selenocysteine residue.";
RL   J. Biol. Chem. 273:8581-8591(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SELENOCYSTEINE AT SEC-498.
RC   TISSUE=Kidney, and Liver;
RX   PubMed=10333487; DOI=10.1042/bj3400439;
RA   Fujiwara N., Fujii T., Fujii J., Taniguchi N.;
RT   "Functional expression of rat thioredoxin reductase: selenocysteine
RT   insertion sequence element is essential for the active enzyme.";
RL   Biochem. J. 340:439-444(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Rundlof A., Arner E.S.J.;
RT   "Molecular cloning of thioredoxin reductase 1 from rat liver.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-20; 56-67; 101-116; 316-335; 365-384; 425-430;
RP   435-459 AND 488-499, FUNCTION, MUTAGENESIS OF SEC-498, CHARACTERIZATION,
RP   CATALYTIC ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10849437; DOI=10.1074/jbc.m000690200;
RA   Zhong L., Holmgren A.;
RT   "Essential role of selenium in the catalytic activities of mammalian
RT   thioredoxin reductase revealed by characterization of recombinant enzymes
RT   with selenocysteine mutations.";
RL   J. Biol. Chem. 275:18121-18128(2000).
RN   [6] {ECO:0007744|PDB:1H6V}
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF MUTANT CYS-498 IN COMPLEX WITH FAD
RP   AND NADP, DISULFIDE BOND, HOMODIMERIZATION, AND COFACTOR.
RX   PubMed=11481439; DOI=10.1073/pnas.171178698;
RA   Sandalova T., Zhong L., Lindqvist Y., Holmgren A., Schneider G.;
RT   "Three-dimensional structure of a mammalian thioredoxin reductase:
RT   implications for mechanism and evolution of a selenocysteine-dependent
RT   enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9533-9538(2001).
CC   -!- FUNCTION: Reduces disulfideprotein thioredoxin (Trx) to its dithiol-
CC       containing form. Homodimeric flavoprotein involved in the regulation of
CC       cellular redox reactions, growth and differentiation. Contains a
CC       selenocysteine residue at the C-terminal active site that is essential
CC       for catalysis (PubMed:10849437). Also has reductase activity on
CC       hydrogen peroxide (H2O2) (PubMed:10849437).
CC       {ECO:0000269|PubMed:10849437}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + NADP(+) = [thioredoxin]-disulfide +
CC         H(+) + NADPH; Xref=Rhea:RHEA:20345, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15378, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.8.1.9;
CC         Evidence={ECO:0000269|PubMed:10849437};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:20347;
CC         Evidence={ECO:0000269|PubMed:10849437};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + H2O2 + NADPH = 2 H2O + NADP(+); Xref=Rhea:RHEA:15173,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.11.1.2;
CC         Evidence={ECO:0000269|PubMed:10849437};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15174;
CC         Evidence={ECO:0000305|PubMed:10849437};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:10849437, ECO:0000269|PubMed:11481439};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:11481439};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.3 uM for thioredoxin {ECO:0000269|PubMed:10849437};
CC         Note=kcat is 2500 min(-1) with thioredoxin as substrate.
CC         {ECO:0000269|PubMed:10849437};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:10849437};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11481439}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q16881}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:Q16881}.
CC   -!- MISCELLANEOUS: The active site is a redox-active disulfide bond. The
CC       selenocysteine residue is also essential for catalytic activity.
CC       {ECO:0000269|PubMed:10849437, ECO:0000269|PubMed:11481439}.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD43039.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH85726.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U63923; AAC35244.2; -; mRNA.
DR   EMBL; AF108213; AAD43039.1; ALT_SEQ; mRNA.
DR   EMBL; AF220760; AAF32362.1; -; mRNA.
DR   EMBL; AF220761; AAF32363.1; -; mRNA.
DR   EMBL; BC085726; AAH85726.1; ALT_INIT; mRNA.
DR   PDB; 1H6V; X-ray; 3.00 A; A/B/C/D/E/F=1-499.
DR   PDB; 3EAN; X-ray; 2.75 A; A/B/C/D/E/F=1-499.
DR   PDB; 3EAO; X-ray; 3.10 A; A/B/C/D/E/F=1-499.
DR   PDB; 4KPR; X-ray; 2.40 A; A/B/E/F=1-499.
DR   PDBsum; 1H6V; -.
DR   PDBsum; 3EAN; -.
DR   PDBsum; 3EAO; -.
DR   PDBsum; 4KPR; -.
DR   SMR; O89049; -.
DR   BioGRID; 248626; 1.
DR   STRING; 10116.ENSRNOP00000013612; -.
DR   BindingDB; O89049; -.
DR   ChEMBL; CHEMBL6035; -.
DR   iPTMnet; O89049; -.
DR   PhosphoSitePlus; O89049; -.
DR   jPOST; O89049; -.
DR   PaxDb; 10116-ENSRNOP00000013612; -.
DR   PeptideAtlas; O89049; -.
DR   UCSC; RGD:61959; rat.
DR   AGR; RGD:61959; -.
DR   RGD; 61959; Txnrd1.
DR   eggNOG; KOG4716; Eukaryota.
DR   InParanoid; O89049; -.
DR   BioCyc; MetaCyc:MONOMER-15194; -.
DR   BRENDA; 1.8.1.9; 5301.
DR   Reactome; R-RNO-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-RNO-499943; Interconversion of nucleotide di- and triphosphates.
DR   Reactome; R-RNO-5263617; Metabolism of ingested MeSeO2H into MeSeH.
DR   Reactome; R-RNO-5628897; TP53 Regulates Metabolic Genes.
DR   SABIO-RK; O89049; -.
DR   EvolutionaryTrace; O89049; -.
DR   PRO; PR:O89049; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0071949; F:FAD binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0045340; F:mercury ion binding; IDA:RGD.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; IDA:RGD.
DR   GO; GO:0050137; F:NADPH peroxidase activity; IDA:UniProtKB.
DR   GO; GO:0033797; F:selenate reductase activity; IDA:RGD.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0042537; P:benzene-containing compound metabolic process; IDA:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0098869; P:cellular oxidant detoxification; ISO:RGD.
DR   GO; GO:0071280; P:cellular response to copper ion; IEP:RGD.
DR   GO; GO:0071455; P:cellular response to hyperoxia; IEP:RGD.
DR   GO; GO:0007369; P:gastrulation; ISO:RGD.
DR   GO; GO:0070276; P:halogen metabolic process; IEP:RGD.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IMP:RGD.
DR   GO; GO:0001707; P:mesoderm formation; ISO:RGD.
DR   GO; GO:0070995; P:NADPH oxidation; IDA:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:RGD.
DR   GO; GO:0010269; P:response to selenium ion; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0016259; P:selenocysteine metabolic process; IMP:RGD.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 2.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer_sf.
DR   InterPro; IPR046952; GSHR/TRXR-like.
DR   InterPro; IPR001100; Pyr_nuc-diS_OxRdtase.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   InterPro; IPR006338; Thioredoxin/glutathione_Rdtase.
DR   NCBIfam; TIGR01438; TGR; 1.
DR   PANTHER; PTHR42737; GLUTATHIONE REDUCTASE; 1.
DR   PANTHER; PTHR42737:SF8; THIOREDOXIN REDUCTASE 1; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   PIRSF; PIRSF000350; Mercury_reductase_MerA; 1.
DR   PRINTS; PR00368; FADPNR.
DR   PRINTS; PR00411; PNDRDTASEI.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
DR   SUPFAM; SSF55424; FAD/NAD-linked reductases, dimerisation (C-terminal) domain; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Disulfide bond; FAD;
KW   Flavoprotein; NADP; Oxidoreductase; Phosphoprotein; Redox-active center;
KW   Reference proteome; Selenocysteine; Ubl conjugation.
FT   CHAIN           1..499
FT                   /note="Thioredoxin reductase 1, cytoplasmic"
FT                   /id="PRO_0000067985"
FT   ACT_SITE        472
FT                   /note="Proton acceptor"
FT   BINDING         18..23
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         42..43
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         58..59
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q16881"
FT   BINDING         63..67
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         131..132
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         161
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         166
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         198..204
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         200
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:Q16881"
FT   BINDING         221..222
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         226..228
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q16881"
FT   BINDING         226
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         291..293
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         315
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q16881"
FT   BINDING         334
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         341..343
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         341
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   BINDING         472
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0007744|PDB:1H6V"
FT   NON_STD         498
FT                   /note="Selenocysteine"
FT                   /evidence="ECO:0000305|PubMed:10849437,
FT                   ECO:0000305|PubMed:11481439"
FT   MOD_RES         68
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JMH6"
FT   MOD_RES         131
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16881"
FT   DISULFID        59..64
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:11481439"
FT   CROSSLNK        497..498
FT                   /note="Cysteinyl-selenocysteine (Cys-Sec)"
FT   MUTAGEN         498
FT                   /note="U->S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10849437"
FT   MUTAGEN         498
FT                   /note="Missing: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10849437"
FT   CONFLICT        52..53
FT                   /note="RW -> NG (in Ref. 1; AAC35244, 2; AAD43039 and 3;
FT                   AAF32362)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        426
FT                   /note="I -> V (in Ref. 4; AAH85726)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451..455
FT                   /note="GFAAA -> ALQP (in Ref. 2; AAD43039 and 3; AAF32362)"
FT                   /evidence="ECO:0000305"
FT   STRAND          12..18
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           22..33
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          38..41
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           57..62
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           64..83
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   TURN            84..87
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           98..122
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          130..136
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          139..143
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          149..159
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          163..165
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          169..172
FT                   /evidence="ECO:0007829|PDB:3EAO"
FT   HELIX           173..176
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           180..183
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          192..196
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           200..211
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          216..222
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           230..242
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          246..260
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          266..277
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          279..289
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          293..296
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   TURN            311..313
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          329..331
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           343..358
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          372..374
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          376..378
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          380..384
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           387..394
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           396..398
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          399..406
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           409..411
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   TURN            412..415
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          421..428
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           429..431
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   STRAND          434..442
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           445..457
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           462..467
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   HELIX           475..480
FT                   /evidence="ECO:0007829|PDB:4KPR"
FT   TURN            486..489
FT                   /evidence="ECO:0007829|PDB:4KPR"
SQ   SEQUENCE   499 AA;  54670 MW;  B23E5B5E661B174E CRC64;
     MNDSKDAPKS YDFDLIIIGG GSGGLAAAKE AAKFDKKVMV LDFVTPTPLG TRWGLGGTCV
     NVGCIPKKLM HQAALLGQAL KDSRNYGWKL EDTVKHDWEK MTESVQNHIG SLNWGYRVAL
     REKKVVYENA YGKFIGPHKI MATNNKGKEK VYSAERFLIA TGERPRYLGI PGDKEYCISS
     DDLFSLPYCP GKTLVVGASY VALECAGFLA GIGLDVTVMV RSILLRGFDQ DMANKIGEHM
     EEHGIKFIRQ FVPTKIEQIE AGTPGRLKVT AKSTNSEETI EDEFNTVLLA VGRDSCTRTI
     GLETVGVKIN EKTGKIPVTD EEQTNVPYIY AIGDILEGKL ELTPVAIQAG RLLAQRLYGG
     STVKCDYDNV PTTVFTPLEY GCCGLSEEKA VEKFGEENIE VYHSFFWPLE WTVPSRDNNK
     CYAKVICNLK DNERVVGFHV LGPNAGEVTQ GFAAALKCGL TKQQLDSTIG IHPVCAEIFT
     TLSVTKRSGG DILQSGCUG
//
